Alnylam Pharmaceuticals Inc.

11/13/2021 | Press release | Distributed by Public on 11/13/2021 07:05

Alnylam Presents New Data for Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension, at the American Heart Association Scientific Sessions 2021